B
Bradford S. Schwartz
Researcher at University of Wisconsin-Madison
Publications - 26
Citations - 3317
Bradford S. Schwartz is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Plasminogen activator & Urokinase. The author has an hindex of 19, co-authored 26 publications receiving 3253 citations. Previous affiliations of Bradford S. Schwartz include University of Illinois at Chicago & Montefiore Medical Center.
Papers
More filters
Journal ArticleDOI
Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders
Douglas B. Cines,Eleanor S. Pollak,Clayton A. Buck,Joseph Loscalzo,Guy A. Zimmerman,Rodger P. McEver,Jordan S. Pober,Timothy M. Wick,Barbara A. Konkle,Bradford S. Schwartz,Elliot S. Barnathan,Keith R. McCrae,Bruce A. Hug,Ann Marie Schmidt,David M. Stern +14 more
TL;DR: The membrane has long been viewed as an inert cellophane-like membrane that lines the circulatory system with its primary essential function being the maintenance of vessel wall permeability.
Journal ArticleDOI
Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes.
N Manchanda,Bradford S. Schwartz +1 more
TL;DR: It is shown that u-PA in its single-chain form exhibits a reactive active site serine, and the enzymatic activity of this molecule is augmented 100-fold upon binding to the u- PA receptor on monocytes as compared with the enzyme activity of the same number of molecules in the fluid phase, likely an important mechanism for the initiation and control of cell surface-associated fibrinolysis.
Journal ArticleDOI
Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
TL;DR: Epsilon-aminocaproic acid is a safe and effective therapy for those patients with acute promyelocytic leukemia who develop coagulopathy associated with low levels of alpha-2-plasmin inhibitor.
Journal ArticleDOI
Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor
Abd Al-Roof Higazi,Robert L. Cohen,Jack Henkin,Douglas A. Kniss,Bradford S. Schwartz,Douglas B. Cines +5 more
TL;DR: The binding of scuPA to cellular and to recombinant soluble urokinase-type plasminogen activator receptors (suPAR) increases its catalytic activity as measured by the cleavage of a uro Kinase-specific chromogenic substrate, suggesting that scu PA may undergo a reversible transformation between a latent and an active state.
Journal ArticleDOI
Antiplatelet activity in onion (Allium cepa) is sulfur dependent.
TL;DR: Evaluation of four onion genotypes grown in a field study at four US locations in 1994 demonstrated onions with mild flavor and low sulfur content exhibited significantly lower antiplatelet activity than those containing high levels of sulfur, demonstrating antiplatelets activity is genotype dependent and correlated with bulb sulfur content.